348
Participants
Start Date
November 30, 2010
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
AA4500
2 injections separated by at least 24 hours but not more than 72 hours, repeated after 42 days (± 5 days) for up to 4 treatment cycles (ie, total of up to 8 injections per subject)
Tauranga Urology Research Ltd., Tauranga
Wellington Urology Associates, Wellington South
Primorus Clinical Trials Ltd., Christchurch
CURT Medical Trials Trust Board Inc., Christchurch
University Urology Associates, New York
Maimonides Medical Center, Division of Urology, Brooklyn
Urologic Consultants of SE PA, Bala-Cynwyd
Virginia Urology, Richmond
Urology of Virginia-Sentara Medical Group, Norfolk
South Florida Medical Research, Aventura
Tristate Urologic Services PSC, Inc./ dba TUG Research, Cincinnati
Northeast Indiana Research, LLC, Fort Wayne
Metropolitan Urology, P.S.C., Jeffersonville
Urology Specialists, S.C., Chicago
Urology Associates Medical Group, Burbank
Connecticut Clinical Research Center, LLC, Middlebury
The Urology Center, P.C., New Haven
Aarhus Universitiy Hospital, Aalborg Sygehus, Aalborg
Frederiksberg Hospital, Frederiksberg
Frederikssunds Hospital, Frederikssund
Klinik for seksuelle dysfunktioner, Gentofte Municipality
Centre Hospitalier Edouar Herriot, Lyon
Hopital Henri Gabrielle, Saint-Genis-Laval
Universitatsklinikum Freiburg, Abteilung Urologie, Freiburg im Breisgau
Private Practice of Urology/Andrology, Hamburg
Uro-Onkologische Praxis Dr. von Keitz, Marburg
Urologische Gemeinschaftspraxis Reutlingen, Reutlingen
Universitatsklinikum Tubingen, Tübingen
"University of Naples Federico II", Naples
Universitiy Tor Vergatat of Rome, Rome
Waitemata Urology Research North Shore Hospital, Takapuna
Cardinal Points Research Ltd., Whangarei
Hospital Clinic de Barcelona, Barcelona
Hospital La Zarzuela, Madrid
Specialistmottagningen i urologi, Gothenburg
Carlshamns Specialistklinik, Karlshamn
Akademiska Sjukhuse, Uppsala
St. Peter's Andrology Centre, London
Sunderland Royal Hospital, Sunderland
Lead Sponsor
Endo Pharmaceuticals
INDUSTRY